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PKD3 (PKCν)The neuropeptides orexin-A/hypocretin-1 (Ox-A) and orexin-B/hypocretin-2 play an important role in the
control of energy metabolism via either of two G-protein-coupled receptors, orexin receptor 1 (Ox1R) and 2.
Despite its signiﬁcant physiological functions, signaling via orexin receptors is still poorly characterized. The
aim of this study was to improve our understanding of early signaling events triggered by the binding of
Ox-A to Ox1R. Using phosphospeciﬁc antibodies, we observed that early kinase activation by Ox-A in a
HEK293 cell line stably expressing Ox1R (HEKOx1R) included ERK1/2, PKCδ, and PKD1. Elevation of
intracellular Ca2+ is a well-characterized response to Ox1R activation. Comparison of Ox-A-induced calcium
elevation and PKD1 activation demonstrated that both responses are detectable soon after stimulation and
increase in a dose-dependent manner, but inhibition of protein kinase C, when low Ox-A concentrations are
used, affects them differently. PKD family of protein kinases has 3 members: PKD1, 2, and 3, which are all
expressed in HEKOx1R cells. In response to stimulation of the cells with 1 nM Ox-A, both PKD1 and PKD3 are
activated and increased in the plasma membrane, pointing at a possible role for these kinases in that cell
compartment. Overexpression of either kinase-dead PKD1 or kinase-dead PKD3 disrupts Ox-A-induced
calcium oscillations demonstrating the functional role of these kinases in modulating physiological responses
to Ox-A.upled receptor; Ox1R, orexin
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Orexins/hypocretins, orexin-A (Ox-A) and -B, are hypothalamic
neuropeptides [1,2] involved in multiple physiological functions
including the regulation of feeding, wakefulness, breathing, repro-
duction, autonomic functions, and energy homeostasis (reviewed in
references [3,4]). They activate two distinct G-protein-coupled
receptors (GPCR), orexin receptor 1 (Ox1R) and 2 [2]. One well-
characterized cellular response to binding of Ox-A to Gq/11-coupled
Ox1R is an elevation of intracellular calcium concentration ([Ca2+]i)[2,5–7]. More recently, we also characterized Ox-A-induced calcium
oscillations in HEK293 cells stably expressing Ox1R (HEKOx1R) [8].
Stimulation of Ox1R by Ox-A has been shown to activate protein
kinases: mitogen-activated protein (MAP) kinases [9–12], protein
kinase C (PKC) [11,13], and Akt [14]. Activation of phospholipases by
GPCR produces lipid second messengers, which are potent activators
of novel PKC (reviewed in [15]) and protein kinase D (PKD) [16–18].
PKD1 has been shown to modulate ion channel trafﬁcking [19] and
activity [20–22].
In this study, we identiﬁed and characterized PKD1 and PKD3
responses to activation of Ox1R by Ox-A in HEKOx1R cells. We found
that they are dose-dependent following a similar dose–response
curve as Ox-A-induced calcium rise. Interfering with either PKD1 or
PKD3 activity affects Ox-A-induced calcium oscillations, demonstrat-
ing the functional relevance of their activation in the physiological
responses to Ox-A.
2. Materials and methods
2.1. Materials
P-(dipropylsulfamoyl)benzoic acid (probenecid), digitonin, and
GF109203X (GF-X) and monoclonal anti-actin antibody were from
Sigma-Aldrich (Helsinki, Finland). Fura-2-acetoxymethyl ester
(fura-2 AM) was from Molecular Probes (Eugene, OR, USA). Human
1207H.M. Peltonen et al. / Biochimica et Biophysica Acta 1803 (2010) 1206–1212orexin-A (Ox-A) was from Neuropeptide (Strasbourg, France).
FuGENE6TM was from Roche Diagnostics (Espoo, Finland). Phospho-
PKC Antibody Sampler Kit, PKD1/PKCμ, Phospho-PKD1/PKCμ Ser744/
748 and PKD1 Ser916 antibodies were from Cell Signaling (Danvers,
MA, USA). Anti-active ERK1/2 was from Promega (Madison, WI, USA).
Full-length A.v. polyclonal anti-GFP antibody and JL8 monoclonal anti-
GFP antibody were from Clontech (Mountain View, CA, USA) and anti-
Ox1R antibody from Alpha Diagnostic International (San Antonio,
TX, USA). Dynabeads Protein G was from Invitrogen (Paisley, UK).
2.2. Cell culture
The generation of HEKOx1R cells has been described earlier [8,23].
The cells were grown in standard Dulbecco's modiﬁed Eagle's cell
culture medium (DMEM; Invitrogen) supplemented with 10%
fetal bovine serum (Invitrogen), 100 U/ml penicillin–streptomycin
(Invitrogen), and 0.05 mg/ml hygromycin (Invitrogen), at 37 °C in 5%
CO2 in an air-ventilated humidiﬁed incubator in 260-ml culture ﬂasks
(Nunc A/S, Roskilde, Denmark) or in 800-ml culture ﬂasks for Ca2+
measurements in suspension.
2.3. Media for Ca2+ measurements
The HEPES-buffered Na+medium (HBM) consisted of the following
(inmM): 137 NaCl, 5 KCl, 1 CaCl2, 0.44 KH2PO4, 4.2 NaHCO3, 10 glucose,
1 probenecid, 20 HEPES, and 1 MgCl2; and the pH was adjusted to 7.4
with NaOH.
2.4. Detection and identiﬁcation of PKD1, 2, and 3 mRNA in HEKOx1R
cells






Total RNA was reverse-transcribed using Revertaid (Fermentas,
Helsinki, Finland). cDNAwas ampliﬁed using Dynazymes (Finnzymes,
Espoo, Finland), 95 °C for 5 minutes, 94 °C/72 °C/55 °C 20 seconds
each, 30 cycles, followed by 5 minutes at 72 °C. PCR products were
puriﬁed and sequenced using ABI Prism system. Sequences were
identiﬁed using Blast [24].
2.5. Transfection of kinase-dead PKD constructs
PKD1K612W-EGFP (PKD1kd) was a gift of A. Hausser [25], and
EGFP-PKD3K605A (PKD3kd) from O. Rey [26]. For transfection,
200,000 HEKOx1R cells were seeded in 35-mm Petri dishes (Nunc
A/S, Roskilde, Denmark) containing a coverslip (25-mm, Merck
Eurolab, Espoo, Finland) in 2 ml of DMEM. After 18–24 hours, cells
were transfected with 6 μl of FuGENE 6 (Roche Diagnostics, Espoo,
Finland) and 1 μg of DNA.
2.6. Ca2+ imaging of single cells and cell suspension
For single-cell Ca2+ imaging experiments, the cells were loaded
with 4 mM fura-2 AM at 37 °C in HBM for approximately 30 minutes.
The coverslip was attached to the bottom of a thermostated (37 °C)
perfusion chamber. Expression of the enhanced green ﬂuorescent
protein (EGFP)-tagged constructs was detected with 450–480 nm UV
light and 520 nm barrier ﬁlter. The cells were excited at the
wavelengths 340/380 nm under the control of an InCyt2™ system
(Intracellular Imaging, Cincinnati, OH, USA). The emitted ﬂuorescence
was measured through a 430-nm dichroic mirror and a 510-nm
barrier ﬁlter with a Cohu CCD camera. A new ratio image (340/380 nm) was collected every second. To investigate the effect of
kinase-dead PKD constructs on peak heights induced by Ox-A, the
cells were challenged by a short pulses of increasing concentrations
(1, 10, and 100 nM) of Ox-A followed by 100 μM oxotremorine.
Because EGFP ﬂuorescence in transfected cells could interfere with the
detected ratio (340/380 nm), response to oxotremorine was used as a
control to normalize Ox-A responses. The results are expressed as
percent of the peak height of the control response. Cells with no
detectable response to 1 nM Ox-A were discarded in the analysis.
Oscillation experiments were performed by stimulating the cells with
1 nM Ox-A for a prolonged period of time. The number of peaks
appearing during the stimulation was calculated and divided by the
duration of the stimulation. The oscillation frequencies are expressed
as peaks per second (Hz). The data from single cell Ca2+ imaging
experiments were imported into Microcal Origin™ 6.0, and further
analysis was performed. Ca2+ measurements in cell suspension were
performed as described earlier [23].
2.7. Data processing
The differences in the responses between two groups were
evaluated by the unpaired Student's t-test. pb0.05 (*) was considered
signiﬁcant. Data are expressed as means±SE.
2.8. Screen for active protein kinase
Cells were plated in 35-mm plates and grown to near conﬂuency,
then treated with 5 nM Ox-A in HBM at 37 °C at indicated times,
buffer was removed, dish was transferred on ice, and cells were lysed
in radioimmunoprecipitation assay buffer (RIPA). Protein concentra-
tionwas determined using BCA™ Protein Assay Kit (Thermo scientiﬁc,
Rockford, IL, USA). About 5–10 μg of protein was run on 7.5% or 10%
acrylamide gel, transferred to polyvinylidene diﬂuoride (PVDF)
membrane, and probed with antibodies according to the manufac-
turer's instructions. Positive bands were detected with ECL+and
scanned on STORM (GE, Uppsala, Sweden).
2.9. PKD3 microscopy and immunoprecipitation
HEKOx1R cells were transfected with EGFP-PKD3 [26], selected
with 400 μg/ml geneticin (Invitrogen, Paisley, UK), and then plated on
coverslips in 12-well plates. At near conﬂuency, mediumwas replaced
with HBM with 1 or 50 nM Ox-A. At selected time, cells were ﬁxed in
formalin, coverslips were mounted on glass slides with anti-fade and
DAPI stain. Fluorescent cells were observed with ﬂuorescence
microscope, Olympus IX71. Images were captured using Olympus
DP controller software. For immunoprecipitation, cells were plated to
60-mm plates, treated in HBM for 5 minutes, then lysed, and
immunoprecipitated with full-length A.v. polyclonal anti-GFP anti-
body cross-linked to Dynabeads protein G. Western blots of
immunoprecipitated proteins were probed with anti-phospho-
PKD1/PKCμSer744/748 and JL8 monoclonal anti-GFP antibody.
2.10. Cell fractionation
HEKOx1R or HEKOx1R-EGFP-PKD3 cells were treated with Ox-A in
HBM. Cytosolic and membrane fractions were isolated according to
Brott et al. [27].
3. Results
To identify protein kinases activated by Ox-A stimulation of Ox1R,
we treated near-conﬂuent HEKOx1R cells with 5 nM Ox-A in HBM and
lysed them at different time points in RIPA buffer. Total protein lysates
were tested by Western blotting and detection with antibodies against
selected phosphorylated PKC subtypes, PKD1, and extracellular signal-
1208 H.M. Peltonen et al. / Biochimica et Biophysica Acta 1803 (2010) 1206–1212regulated kinases 1 and 2 (ERK1/2). Phosphorylated forms of ERK1/2,
PKCδ, and PKD1 were increased in a time-dependent manner in Ox-A-
treated samples compared tountreated controls, but phosphorylation of
PKCα/β T638/641 was unaffected by Ox-A treatment (Fig. 1A). The
experiment was repeated three times with similar results. The ﬁrst
detectable response in this assaywas thephosphorylation of PKD1S916,
whichwas always observed already in the ﬁrst lysate (75 s or less). The
phosphorylation of ERK1/2 was detected after about 90 seconds of
treatment. Themaximumdetectable phosphorylation levelwas reached
after 3 minutes in the case of ERK1/2 and around 5 minutes in the case
of PKD1. ERK1/2 were only transiently phosphorylated. ERK2 phos-
phorylation remained detectable longer, but both started to decline
towards baseline after 5 minutes. Phosphorylation of PKD1 was
sustained for at least 1 hour (Fig. 1B). PKCδ phosphorylation was also
detected in the ﬁrst lysate but was less sustained after 30 minutes
(Fig. 1B).
Phosphorylation of residue serine 916 in the active loop correlates
well with the active state of PKD1 [28] (Fig. 1A). We could therefore
useWestern blot to characterize PKD1 response to Ox-A. We aimed to
compare the newly identiﬁed PKD1 response with [Ca2+]i elevation,
which is a well-characterized response of Ox1R activation. Both
responses were detectable very early (around 1 minute) after theFig. 1. Ox-A-induced phosphorylation of protein kinases. (A) Representative Western
blot of HEKOx1R cells treated with 5 nMOx-A for various times (indicated in the ﬁgure)
and probed with anti-active ERK, anti-PKD1 S916p, anti-PKCα/β T638/641p, anti-PKCδ
T505p, and anti-actin (positive control). Ctrl 0 s (ﬁrst lane) and Ctrl 1 h (last lane)
represent control samples treated with vehicle 0 second and 1 hour, respectively.
(B) Time proﬁles of ERK1/2, PKD1 and PKCδ phosphorylation obtained by quantifying
the scanned blots from experimental conditions similar to (A) with ImageQuant
(n=3). Data are presented as percent of maximal response.stimulation. HEKOx1R cells responded to stimulation of Ox1R with
intracellular calcium rise already when as little as 0.3 nM Ox-A was
used. A stepwise increase in stimulating Ox-A concentration to
100 nM caused a concentration-dependent increase in this response
(Fig. 2A). Similarly, already a low concentration of Ox-A (1 nM) was
sufﬁcient to induce detectable phosphorylation of PKD1 S916 residue
(Fig. 2B). The peak of the response to 1 nM Ox-A occurred at
5 minutes. This time point was chosen to establish the dose-response
curve presented in Fig. 2C (solid line). An apparent saturation of the
response was reached with Ox-A concentration of 20 nM. The dose
responses of Ox-A-induced PKD1 phosphorylation and [Ca2+]i
elevation were superimposable (Fig. 2C).
Because of the similarity between the two responses, further
investigations were made to determine whether they are linked toFig. 2. Comparison of Ox-A-induced calcium and PKD1 responses. (A) Representative
Ca2+ imaging recording with fura-2 AM from single HEKOx1R cell stimulated by
increasing nM concentrations of Ox-A indicated in the ﬁgure and by 100 μM
oxotremorine (M, positive control) at time points indicated by arrows.
(B) Representative Western blot of HEKOx1R cells treated with increasing nM
concentrations of Ox-A indicated in the ﬁgure and probed with anti-PKD1 S916p and
anti-actin (positive control). (C) Dose–response curves of [Ca2+]i elevation obtained
from Ca2+ imaging recordings with fura-2 AM from cell suspensions of HEKOx1R cells
stimulated by increasing concentrations of Ox-A (n=9–40) and of PKD1 activation
obtained by quantifying the scanned blots from experimental conditions similar to
(B) with ImageQuant (n=2). Data are presented as percent of maximal response±SE.
Fig. 3. Effect of PKC on Ox-A-induced calcium and PKD1 responses. (A) Representative
Western blot of HEKOx1R cells treated with 1 nMOx-A for 5 minutes in the absence and
presence of PKC inhibitor GF-X (1 μM) as indicated in the ﬁgure and probed with anti-
PKD1 S916p and anti-actin (positive control). (B) Comparison of the effects of GF-X on
calcium and PKD1 responses. [Ca2+]i elevations in the absence and presence of 1 μM
GF-X were determined in Ca2+ imaging recordings with fura-2 AM from cell
suspensions of HEKOx1R cells stimulated by increasing concentrations of Ox-A
indicated in the ﬁgure (n=2–18). PKD1 activation was obtained by quantifying
(ImageQuant) the scanned blots (n≥3) from experimental conditions similar to
(A) with increasing concentrations of Ox-A. Responses in the presence of GF-X were
compared with the responses without GF-X, and data are presented as percent of
control response±SE.
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described as being calcium-independent [29,30]. Most studies have
found that PKD1 activation by GPCR is PKC-dependent [16,17,31,32].
We tested the importance of PKC using the PKC inhibitor GF-X and
found that PKD1 phosphorylation induced by 1 nM Ox-A was clearly
(approximately by 70%) inhibited by the treatment (Fig. 3A). In
contrast, calcium response to low Ox-A concentration was unaffected
by GF-X treatment. At higher concentrations (10 nM and above), GF-X
showed a comparable inhibitory effect on both PKD1 and calcium
responses (Fig. 3B).
Different cell types express different subtypes of PKDs. Using RT–
PCR with subtype speciﬁc primers, we detected PKD1, PKD2, and
PKD3 mRNA in HEKOx1R cells (conﬁrmed by sequencing). PKD3 does
not have the S916 phosphorylation site, but activation of all three PKD
subtypes can be detected using an antibody against phosphorylated
serine residue 744/748 in the active loop (reviewed in [33]). To be
certain of the subtype identity, we used HEKOx1R cells stably
transfected with an EGFP-tagged PKD3 construct [26]. Immunopre-
cipitation with anti-GFP antibody of control and Ox-A-treated cells,
and subsequent Western blot detection with anti-active PKD(744/
748) showed increased phosphorylation of PKD3 after stimulating
HEKOx1R cells with 1 nM Ox-A for 5 minutes (Fig. 4A). Higher
concentrations of Ox-A increased the detectable level of phosphory-
lated PKD3.
Activation of PKD1 and PKD3 leads to their translocation to other
cell compartments [32,34–37]. To conﬁrm that both PKD1 and PKD3
are activated by Ox-A, we investigated if they were translocated and
where. Cell fractionation experiments indicated that the quantity ofPKD1 was increased in a dose-dependent manner in membrane
fraction after a 5 minutes treatment of the cells with Ox-A (Fig. 4B;
anti-Ox1R antibody was used as a control to conﬁrm loading of the
membrane fraction). The membrane localization of PKD3 was also
demonstrated by visualization of EGFP-tagged PKD3 by ﬂuorescence
microscopy. In untreated cells, the ﬂuorescence was uniformly
distributed throughout the cells. Treatment of the cells with Ox-A
(1 nM or 50 nM) markedly brightened the ﬂuorescence at the
periphery of the cells (Fig. 4C).
When stimulated by 1 nM Ox-A for prolonged periods of time
HEKOx1R cells show an oscillating response pattern which is
independent of calcium discharge from intracellular calcium stores
and involves canonical transient receptor potential channel 3 (TRPC3)
channels [8]. To test if PKD1 or PKD3 had a role in the modulation of
this type of oscillating calcium entry, we transfected HEKOx1R cells
with EGFP-tagged kinase-dead PKD1 (PKD1kd) [25] and EGFP-tagged
kinase-dead PKD3 (PKD3kd) [26] and conducted single-cell Ca2+
imaging experiments. Neither construct had any signiﬁcant effect on
peak amplitudes of calcium responses induced by Ox-A (comparison
of ﬂuorescent cells expressing kinase-dead construct with nonﬂuo-
rescent control cells on the same plate). When stimulating the cells
with 1 nMOx-A, the peak height of PKD1 kinase-dead expressing cells
(n=48) was 125±12% and control cells (nonﬂuorescent, n=53)
145±14% (peak heights expressed as % of the peak height of a
subsequent addition of 100 μM oxotremorine). Corresponding values
for PKD3kd (n=63) and its control (n=71) were 147±6% and
137±5%. The recorded oscillation patterns were, however, consider-
ably altered. Overexpression of PKD1kd increased the frequency of the
oscillations by approximately 1 peak for every 10 minutes of
stimulation (6.2±0.4 mHz in PKD1kd-expressing ﬂuorescent cells
(n=62) versus 4.9±0.3 mHz in control cells (n=42); Fig. 5A). The
observed increase was statistically signiﬁcant (Fig. 5B). On the other
hand, overexpression of PKD3kd in HEKOx1R cells completely
disrupted the oscillation pattern (Fig. 6A). Only a sustained [Ca2+]i
elevation remained. The number of transiently oscillating cells was
signiﬁcantly decreased in this cell group compared to corresponding
nonﬂuorescent control group (Fig. 6B). The oscillation frequency of
the ﬂuorescent cells showing oscillations did not differ from the
controls (6.7±0.6 mHz in PKD3kd-expressing ﬂuorescent cells
(n=15) versus 6.5±0.4 mHz in control cells (n=38)).
4. Discussion
In spite of their high potential as drug targets (reviewed in
references [3,4]), cellular events triggered by the activation of orexin
receptors remain poorly understood. One of the most notable
responses elicited by low concentrations of Ox-A is an entry of
calcium into the stimulated cells [7,8,23,38–40]. This response is
modiﬁed by the activation of protein kinases [5,6,39–41]. Ox-A has
previously been shown to activate ERK1/2 [9–12]. We show here a
fast Ox-A-induced phosphorylation of PKCδ and PKC-dependent
activation of PKD1. All three members of PKD family (PKD1, 2, and
3) were detectable in HEKOx1R cells by RT–PCR, and in addition to
PKD1, we observed an activation of PKD3 in the same conditions and
at the same time.
PKD activation is a two-step event starting with diacylglycerol
(DAG) binding to the C1 domain followed by phosphorylation by PKC
[36,42]. Ox-A-induced activation of PKD1 follows the same pattern,
which, in this study, was demonstrated by the inhibition of PKD1
activation by a broad-spectrum PKC inhibitor: GF-X. PKCε, which has
been shown to be rapidly translocated to the membrane in response
to Ox-A [11], and PKCδ, which, in this study, was activated following a
similar time pattern as PKD1 and has been shown to be associated
with PKD1 [43,44], are two likely candidates for the control of Ox-A-
induced PKD1 activity. Once activated, PKDs are usually translocated
to speciﬁc cellular compartments: membrane [34,36], nuclei [35,45],
Fig. 4. Ox-A-induced activation and localization of PKD1 and PKD3. (A) Representative Western blot of HEKOx1R-EGFP-PKD3 cells treated with vehicle, 1, 20, or 50 nM Ox-A for
5 minutes, immunoprecipitated with polyclonal anti-GFP antibody, and probed with anti-active PKD (S744/748P) (n=4) and with anti-GFP (positive control). (B) Representative
Western blots of cell membrane fraction of HEKOx1R and HEKOx1R-EGFP-PKD3 cells treated with vehicle, 1 nM or 50 nM Ox-A for 5 minutes and probed with monoclonal anti-GFP
in the case of PKD3 (n=2), with anti-PKD1/PKCμ in the case of PKD1 (n=3), and with anti-Ox1R as a positive control (n=3). (C) Epi-ﬂuorescence microscopy images of
HEKOx1R-EGFP-PKD3 cells treated with vehicle (control), 1 nM or 50 nM Ox-A for 5 and 30 minutes.
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downstream effectors. Here we show an increase of both PKD1 and
PKD3 in membrane fractions as a result of Ox1R stimulation by Ox-A.Fig. 5. Effect of kinase-dead construct of PKD1 (PKD1kd) on Ox-A-induced calcium
oscillations. (A) Representative single cell Ca2+ imaging recordings with fura-2 AM
from a control cell (left) and a PKD1kd-expressing cell (right) stimulated by 1 nM Ox-A
for times indicated by horizontal bars. The cells successfully transfected by PKD1kd
were identiﬁed based on EGFP ﬂuorescence. (B) Summary of oscillation frequency data
obtained from experimental conditions similar to (A). The oscillation frequencies of
transiently oscillating PKD1kd-expressing (n=62) and control (nonﬂuorescent) cells
(n=42) from same experiments were calculated as spikes per second (Hz) and
compared. The oscillation frequency of control group was set as 100%, and the results
are presented as percent frequency±SE.The primary activators of PKDs, DAG and PKC, also play important
roles in the control of Ox-A-induced calcium response [5,6,39–41].
TRPC3, the main channel involved in Ca2+ inﬂux activated by Ox1RFig. 6. Effect of kinase-dead construct of PKD3 (PKD3kd) on Ox-A-induced calcium
oscillations. (A) Representative single cell Ca2+ imaging recordings with fura-2 AM
from a control cell (left) and a PKD3kd-expressing cell (right) stimulated by 1 nM Ox-A
for times indicated by horizontal bars. The cells successfully transfected with PKD3kd
were identiﬁed based on EGFP ﬂuorescence. (B) Summary of proportions of transiently
oscillating cells obtained from experimental conditions similar to (A). The percentages
of transiently oscillating cells from all ﬂuorescent cells expressing PKD3kd (n=65)
were calculated and compared with the corresponding percentages from nonﬂuores-
cent control cells (n=74) from the same experiments. The proportions of oscillating
cells in control groups were set as 100%, and the results are presented as percent
oscillating cells±SE.
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inhibited by PKC [49,50], which likely explains the absence of effect
of PKC inhibitor GF-X in this case. Ca2+ responses to higher
concentrations of Ox-A result from the activation of multiple
signaling pathways, including PLCβ pathway, leading to discharge
of Ca2+ from the intracellular stores [51], and PLA2 pathway, leading
to generation of arachidonic acid [8]. PKC is known to phosphorylate
and regulate the function of for example IP3R and PLA2 among a
plethora of other proteins participating in the regulation of Ca2+
signaling in cells (for review, see [52]). Thus, the exact mechanism
of GF-X-induced inhibition is difﬁcult to pinpoint, although many
possible targets exist.
The speciﬁc PKC subtypes involved in Ox-A-induced Ca2+
response have not been identiﬁed and the modulatory effects
resulting from PKC activation could also be indirect. Our initial
investigation of the role of PKD subtypes showed that neither
overexpression of kinase-dead PKD1 (PKD1kd) [25] nor kinase-dead
PKD3 (PKD3kd) [26] signiﬁcantly affected the amplitudes of calcium
responses, but recent characterization of Ox-A-induced calcium
oscillations [8] opened other avenues for the investigation of the
role of PKDs in orexin signaling.
Calcium oscillations in response to GPCR stimulation are recog-
nized to be an important and widespread signaling mechanism [53].
The pattern and frequency of calcium oscillations encode for different
regulation of cellular functions, for instance, gene regulation and
metabolism [54–56]. Calcium oscillations induced by 1 nM Ox-A in
HEKOx1R cells are dependent on extracellular Ca2+ and sensitive to
Mg2+ but not dependent on intracellular calcium store release and
capacitative calcium entry [8]. In addition, phospholipase A2 and the
ion channel TRPC3 were shown to be essential for the generation of
these speciﬁc oscillations. Both PKD1kd and PKD3kd affected 1 nM
Ox-A-induced calcium oscillations but not in a similar manner:
PKD1kd signiﬁcantly increased the oscillation frequency while
PKD3kd caused an apparent disruption of the oscillatory pattern.
Although the effect of PKD3kd appeared very similar to that of
dominant-negative TRPC3 [8], TRPC3 is unlikely to be the primary
target of PKD phosphorylation because our careful analysis of TRPC3
sequence revealed no consensus sites for PKD phosphorylation. The
effect of PKD3kd also differed from that of the dominant-negative
TRPC3 since no effect was observed on the magnitude of the peak
[Ca2+]i elevation, which, on the other hand, was considerably
attenuated by interference with TRPC3 function.
PKD1 has been shown to control a number of ion channels by
different mechanisms [19–21,57]. Unlike for PKD1, speciﬁc roles for
PKD3 in ion channel regulation have not been reported so far. Several
recent reports may explain how activities of the different PKD
subtypes can be differentially regulated and targeted by the same
stimulus: each subtype has a different afﬁnity for DAG [45] and PKD1
and 2 have an additional C-terminal autophosphorylation site missing
from the shorter PKD3 (reviewed in [33]). Finally, PKD3 lacks the C-
terminal PDZ-domain, which prevents it from binding certain
partners of PKD1 and PKD2 [58,59]. Receptors are probably embedded
inside big signaling complexes including many components, among
which TRPC channels [60], anchoring proteins like ﬁlamin-A [61,62]
or Homer [63] play a role in controlling Ca2+ responses induced by
receptor stimulation. Assuming that molecules participating in Ox1R
signaling are similarly organized around the receptor, PKD1 and PKD3
anchored at different locations in the complex and phosphorylating
different proteins are likely to be part of the control mechanism
responsible for Ox-A-induced oscillation pattern.5. Conclusions
In conclusion, we describe a novel signaling pathway activated by
Ox1R stimulation in well-characterized conditions. This pathwayinvolves activation and membrane translocation of PKD1 and PKD3
followed by modulation of Ox-A-induced calcium oscillations.Acknowledgments
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